指南与共识儿科与产科急症重症综合管理与镇静镇痛

儿童及新生儿肿瘤患者预防性红细胞输注:一项基于证据的临床实践指南

Prophylactic red blood cell transfusions in children and neonates with cancer: An evidence-based clinical practice guideline.
指南 / 共识 · Support Care Cancer · 2024-11-04
一句话结论该指南基于4项研究203例患儿及专家共识制定47条推荐,为脓毒症、ECMO、放疗等特定情境下儿童及新生儿肿瘤患者的预防性红细胞输注提供阈值建议。

该指南针对儿童及新生儿肿瘤患者预防性红细胞输注缺乏循证推荐的问题,采用系统文献综述(3个数据库)和GRADE方法评估证据,组建21人多学科专家组,在证据不足时参考普通儿科或成人肿瘤指南或采用专家共识,经多次面对面会议制定推荐。最终纳入4项研究共203例各类肿瘤患儿,形成47条关于红细胞输注的推荐,包括脓毒症、ECMO、放疗等特定情境的预防性输注阈值。该指南旨在指导临床医生改善患儿结局。

要点

  • 该指南针对儿童及新生儿肿瘤患者预防性红细胞输注,共形成47条推荐。
  • 证据基础为4项研究共203例各类肿瘤患儿,并辅以专家共识。
  • 指南推荐了脓毒症、ECMO、放疗等特定情境下儿童及新生儿肿瘤患者的预防性红细胞输注阈值。
  • 证据不足时参考普通儿科或成人肿瘤指南,或由21人多学科专家组采用共享专家意见制定推荐。
  • 采用GRADE方法评估、提取和总结证据,并通过证据到决策框架形成推荐。

适用人群与场景

  • 儿童及新生儿肿瘤患者(4项研究共203例各类肿瘤患儿)。

处置流程与药物剂量

  • 对合并脓毒症的儿童及新生儿肿瘤患者,指南推荐了特定的预防性红细胞输注阈值。
  • 对接受ECMO的儿童及新生儿肿瘤患者,指南推荐了特定的预防性红细胞输注阈值。
  • 对正在接受放疗的儿童及新生儿肿瘤患者,指南推荐了特定的预防性红细胞输注阈值。

研究设计与关键结果

  • 该指南为临床实践指南,采用系统文献综述(3个数据库)和GRADE方法评估证据,组建21人多学科专家组,经多次面对面会议讨论证据、完成证据到决策框架并制定推荐。
  • 共纳入4项研究、203例各类肿瘤患儿符合纳入标准。
  • 专家组评估全部证据并转化为推荐,共制定47条关于儿童及新生儿肿瘤患者红细胞输注的推荐。
  • 推荐包括合并脓毒症、接受ECMO或正在接受放疗的儿童及新生儿肿瘤患者的特定预防性红细胞输注阈值。
  • 证据不足时,补充收集普通儿科或成人肿瘤指南证据,或由专家组采用共享专家意见制定综合指南。

证据类型、等级与局限

  • 证据类型:临床实践指南,基于系统文献综述和GRADE方法。
  • 共纳入4项研究、203例患儿,证据数量有限,部分推荐基于专家共识。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 该指南为儿童及新生儿肿瘤患者预防性红细胞输注提供基于证据的推荐,旨在指导临床医生并改善患儿结局。
  • 对合并脓毒症、接受ECMO或正在接受放疗的儿童及新生儿肿瘤患者,可参考指南推荐的特定预防性红细胞输注阈值。

指南或共识出处

  • 指南名称:儿童及新生儿肿瘤患者预防性红细胞输注:一项基于证据的临床实践指南(Support Care Cancer)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Red blood cell (RBC) transfusions play an important role in supportive care in children and neonates with cancer. However, in current clinical practice, evidence-based recommendations are lacking on when to administer prophylactic RBC transfusions. To address this gap, a clinical practice guideline (CPG) was developed to systematically review the available evidence and provide recommendations for clinicians.

METHODS: A systematic literature review in three databases was conducted. The GRADE methodology was used to assess, extract, and summarize the evidence. A multidisciplinary panel of 21 professionals was assembled to ensure comprehensive expertise. If there was insufficient evidence in children with cancer, additional evidence was gathered in general pediatric or adult oncology guidelines, or the panel utilized shared expert opinion to develop a comprehensive CPG. Multiple in-person meetings were conducted to discuss evidence, complete evidence-to-decision frameworks, and formulate recommendations.

RESULTS: Four studies including 203 children with all types of cancer, met the inclusion criteria. The expert panel assessed all evidence and translated it into recommendations. In total, 47 recommendations were formulated regarding RBC transfusions in children and neonates with cancer. For instance, specific thresholds for prophylactic RBC transfusions were recommended for children and neonates with cancer who have sepsis, are on ECMO, or are undergoing radiotherapy.

CONCLUSION: This clinical practice guideline presents evidence-based recommendations regarding RBC transfusions in children and neonates with cancer. By providing these recommendations, we aim to guide clinicians and contribute to improving outcomes for children and neonates with cancer.

来源:Support Care Cancer,查看原文。版权归原作者所有。

参考来源

  1. Kruimer DM, Stavleu DC, Mulder RL, et al. Prophylactic red blood cell transfusions in children and neonates with cancer: An evidence-based clinical practice guideline. Support Care Cancer. 2024. PMID: 39495315. doi:10.1007/s00520-024-08888-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。